Table 3.
Serum 8-iso-PGF2-alpha levels at T0
| Treatment Group Subject Number | 8-iso-PGF2-alpha (pg/mL) | Control Group Subject Number | 8-iso-PGF2-alpha (pg/mL) |
|---|---|---|---|
| 1 | 1431.2 | 17 | 310.9 |
| 2 | 323.7* | 18 | 131.9* |
| 3 | 946.8 | 19 | 1011.5 |
| 4 | 678.7 | 20 | 22.1* |
| 5 | 974 | 21 | 1121 |
| 6 | 772.4 | 23 | 107* |
| 7 | 770.9 | 24 | 818 |
| 8 | 330.2* | 25 | 206.4* |
| 9 | 728.4 | 26 | 1503 |
| 10 | 965.2 | 27 | 414.5 |
| 11 | 308.9* | 28 | 356.4 |
| 12 | 756.9 | 29 | 373.4 |
| 13 | 1432.8 | 30 | 11901 |
| 14 | 255.2* | 31 | 344.5 |
| 15 | 582.2* | 32 | 294 |
| 16 | 728.4* | ||
1subject data excluded due to hemolysis
*subjects excluded from subgroup analysis due to lowest 8-iso-PGF2-alpha levels